US Bancorp
ARVN icon

US Bancorp’s Arvinas ARVN Stock Holding History

US Bancorp’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74K Sell
209
-672
-76% -$6.27K ﹤0.01% 3899
2026
Q1 		$9.34K Sell
881
-10
-1% -$124 ﹤0.01% 3381
2025
Q4 		$10.6K Sell
891
-111
-11% -$1.21K ﹤0.01% 3315
2025
Q3 		$8.54K Buy
1,002
+262
+35% +$1.99K ﹤0.01% 3364
2025
Q2 		$5.45K Sell
740
-321
-30% -$2.36K ﹤0.01% 3615
2025
Q1 		$7.45K Sell
1,061
-445
-30% -$6.97K ﹤0.01% 3535
2024
Q4 		$28.9K Sell
1,506
-169
-10% -$4.11K ﹤0.01% 2999
2024
Q3 		$41.3K Sell
1,675
-313
-16% -$8.17K ﹤0.01% 2833
2024
Q2 		$52.9K Sell
1,988
-309
-13% -$9.85K ﹤0.01% 2646
2024
Q1 		$94.8K Sell
2,297
-23
-1% -$1K ﹤0.01% 2391
2023
Q4 		$95.5K Buy
2,320
+1,692
+269% +$39.6K ﹤0.01% 2370
2023
Q3 		$12.3K Sell
628
-28
-4% -$687 ﹤0.01% 3089
2023
Q2 		$16.3K Buy
656
+190
+41% +$4.89K ﹤0.01% 3073
2023
Q1 		$12.7K Buy
466
+163
+54% +$5.15K ﹤0.01% 3192
2022
Q4 		$10.4K Sell
303
-50
-14% -$2.1K ﹤0.01% 3286
2022
Q3 		$16K Sell
353
-240
-40% -$11.7K ﹤0.01% 3133
2022
Q2 		$25K Sell
593
-520
-47% -$26.1K ﹤0.01% 2923
2022
Q1 		$75K Sell
1,113
-18,264
-94% -$1.24M ﹤0.01% 2412
2021
Q4 		$1.59M Sell
19,377
-360
-2% -$29.3K ﹤0.01% 1002
2021
Q3 		$1.62M Buy
19,737
+2,745
+16% +$243K ﹤0.01% 958
2021
Q2 		$1.31M Buy
16,992
+16,472
+3,168% +$1.14M ﹤0.01% 1067
2021
Q1 		$35K Buy
520
+373
+254% +$28.5K ﹤0.01% 2754
2020
Q4 		$12K Buy
+147
New +$5.07K ﹤0.01% 3104
2020
Q3 		– Sell
-603
Closed -$20K – 3701
2020
Q2 		$20K Sell
603
-831
-58% -$35.3K ﹤0.01% 2807
2020
Q1 		$57K Sell
1,434
-46
-3% -$2.15K ﹤0.01% 2299
2019
Q4 		$61K Hold
1,480
– – ﹤0.01% 2379
2019
Q3 		$32K Buy
+1,480
New +$36.3K ﹤0.01% 2651

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

US Bancorp's ARVN Position: Q2 2026 in Review

US Bancorp reduced its Arvinas (ARVN) stake by 76% in Q2 2026, selling an estimated $6.27K and leaving 209 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #3899.

US Bancorp first reported a position in ARVN in Q3 2019 and has held it in 27 quarters since. The position peaked at $1.62M in Q3 2021. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • US Bancorp held 209 shares of Arvinas worth $1.74K as of Q2 2026.
  • US Bancorp sold 672 Arvinas shares in Q2 2026, an estimated $6.27K.
  • Arvinas made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3899 holding.
  • US Bancorp first reported a position in Arvinas in Q3 2019 and has held it in 27 quarters since.
  • US Bancorp's Arvinas position peaked at $1.62M in Q3 2021.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.